MINGZHAOMING ZHAO12713ZHAO, MINGAssistant Professor - SHPplugins:TwitterTwitterprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson11Assistant Professor - SHPBioinformatics & Computational BiologyGI Medical OncologyHematopathologyInvestigational Cancer TherapeuticsLeukemiaMolecular & Cellular OncologySchool of Health ProfessionsMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorLEIHUOLEI HUO9168HUO, LEIAssociate ProfessorJAFFER AAJANIJAFFER A AJANI8473AJANI, JAFFER AProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorZHENYATANGZHENYA TANG9946TANG, ZHENYAAssistant ProfessorFUNDAMERIC-BERNSTAMFUNDA MERIC-BERNSTAM8778MERIC-BERNSTAM, FUNDAProfessorSRDANVERSTOVSEKSRDAN VERSTOVSEK8781VERSTOVSEK, SRDANProfessorXIAOPINGSUXIAOPING SU9720SU, XIAOPINGAssociate Professor26431029Song X, Zhang C, Zhao M, Chen H, Liu X, Chen J, Lonard DM, Qin L, Xu J, Wang X, Li F, O'Malley BW, Wang JPloS oneSteroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug. PLoS One. 2015; 10(10):e0140011.PLoS One2015-10-02T00:00:002015Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug.74Professor10Assistant Professor14Associate Professor15983119Wang RA, Zhao M, Meistrich ML, Kumar RThe journal of histochemistry and cytochemistry : official journal of the Histochemistry SocietyStage-specific expression of dynein light chain-1 and its interacting kinase, p21-activated kinase-1, in rodent testes: implications in spermiogenesis. J Histochem Cytochem. 2005 Oct; 53(10):1235-43.J Histochem Cytochem2005-06-27T00:00:002005Stage-specific expression of dynein light chain-1 and its interacting kinase, p21-activated kinase-1, in rodent testes: implications in spermiogenesis.26806071Chen J, Zhao M, Jiang X, Sizovs A, Wang MC, Provost CR, Huang J, Wang JThe AnalystGenetically anchored fluorescent probes for subcellular specific imaging of hydrogen sulfide. Analyst. 2016 Feb 21; 141(4):1209-1213.Analyst2016-02-21T00:00:002016Genetically anchored fluorescent probes for subcellular specific imaging of hydrogen sulfide.27021842Liu X, Lu YF, Guan X, Zhao M, Wang J, Li FBiochemical pharmacologyCharacterizing novel metabolic pathways of melatonin receptor agonist agomelatine using metabolomic approaches. Biochem Pharmacol. 2016 06 01; 109:70-82.Biochem Pharmacol2016-03-25T00:00:002016Characterizing novel metabolic pathways of melatonin receptor agonist agomelatine using metabolomic approaches.27084884Song X, Chen J, Zhao M, Zhang C, Yu Y, Lonard DM, Chow DC, Palzkill T, Xu J, O'Malley BW, Wang JProceedings of the National Academy of Sciences of the United States of AmericaDevelopment of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3. Proc Natl Acad Sci U S A. 2016 May 03; 113(18):4970-5.Proc Natl Acad Sci U S A2016-04-15T00:00:002016Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3.23848502Chen J, Zhao M, Feng F, Sizovs A, Wang JJournal of the American Chemical SocietyTunable thioesters as "reduction" responsive functionality for traceless reversible protein PEGylation. J Am Chem Soc. 2013 Jul 31; 135(30):10938-41.J Am Chem Soc2013-07-16T00:00:002013Tunable thioesters as "reduction" responsive functionality for traceless reversible protein PEGylation.21293030Iwamori N, Zhao M, Meistrich ML, Matzuk MMBiology of reproductionThe testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol Reprod. 2011 Jun; 84(6):1225-34.Biol Reprod2011-02-03T00:00:002011The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility.18430928Zhao M, Szafranski P, Hall CA, Goode SGeneticsBasolateral junctions utilize warts signaling to control epithelial-mesenchymal transition and proliferation crucial for migration and invasion of Drosophila ovarian epithelial cells. Genetics. 2008 Apr; 178(4):1947-71.Genetics2008-04-01T00:00:002008Basolateral junctions utilize warts signaling to control epithelial-mesenchymal transition and proliferation crucial for migration and invasion of Drosophila ovarian epithelial cells.18549275Chan PK, Zhao M, Che CT, Mak EJournal of natural productsCytotoxic acylated triterpene saponins from the husks of Xanthoceras sorbifolia. J Nat Prod. 2008 Jul; 71(7):1247-50.J Nat Prod2008-06-13T00:00:002008Cytotoxic acylated triterpene saponins from the husks of Xanthoceras sorbifolia.1515 Holcombe BlvdHouston77030-4009TX0.7224780.00734623247research areas3.454890.029344667coauthor of29.07975.9521860similar to1137selected publicationsAuthorship 858081Authorship 858814Journal of Histochemistry and CytochemistryErratum to Stage-specific expression of dynein light chain-1 and its interacting kinase, p21-activated kinase-1, in rodent testes. Journal of Histochemistry and Cytochemistry. 61:396.Erratum to Stage-specific expression of dynein light chain-1 and its interacting kinase, p21-activated kinase-1, in rodent testesChinese Journal of Biomedical EngineeringInfluence of polyvinylchloride catheter on the blood tissue factor activity. Chinese Journal of Biomedical Engineering. 18.Influence of polyvinylchloride catheter on the blood tissue factor activity28810913Arango NP, Yuca E, Zhao M, Evans KW, Scott S, Kim C, Gonzalez-Angulo AM, Janku F, Ueno NT, Tripathy D, Akcakanat A, Naing A, Meric-Bernstam FBreast cancer research : BCRSelinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer. Breast Cancer Res. 2017 Aug 15; 19(1):93.Breast Cancer Res2017-08-15T00:00:002017Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.Authorship 8859592Authorship 8861365Authorship 8863451Authorship 8865892Authorship 8866412Authorship 8866688Authorship 8867282Authorship 8870874Authorship 8873423Authorship 8879874Authorship 8882054Authorship 8888033Authorship 8894412Authorship 8898383D057054Procedures1161840.842146Molecular ImagingD018719Chemicals & Drugs51925130.4861Receptor, ErbB-230358421Jiang X, Zhang C, Chen J, Choi S, Zhou Y, Zhao M, Song X, Chen X, Maletic-Savatic M, Palzkill T, Moore D, Wang MC, Wang JAntioxidants & redox signalingQuantitative Real-Time Imaging of Glutathione with Subcellular Resolution. Antioxid Redox Signal. 2019 06 01; 30(16):1900-1910.Antioxid Redox Signal2018-12-20T00:00:002018Quantitative Real-Time Imaging of Glutathione with Subcellular Resolution.D009196Disorders1397660.579244Myeloproliferative DisordersAuthorship 8975251Authorship 9306726Authorship 932236815163613Zhao M, Shirley CR, Mounsey S, Meistrich MLBiology of reproductionNucleoprotein transitions during spermiogenesis in mice with transition nuclear protein Tnp1 and Tnp2 mutations. Biol Reprod. 2004 Sep; 71(3):1016-25.Biol Reprod2004-05-26T00:00:002004Nucleoprotein transitions during spermiogenesis in mice with transition nuclear protein Tnp1 and Tnp2 mutations.30576868Tang G, Hu S, Wang SA, Xie W, Lin P, Xu J, Toruner G, Zhao M, Gu J, Doty M, Li S, Medeiros LJ, Tang ZThe Journal of molecular diagnostics : JMDt(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression. J Mol Diagn. 2019 03; 21(2):343-351.J Mol Diagn2018-12-19T00:00:002018t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.PathologyBaylor College of MedicineJINWANGJIN WANG0.000000000000000.000000000000001912WANG, JINProfessorAuthorship 943757130713601Zhao M, Zhuo ML, Zheng X, Su X, Meric-Bernstam FOncotargetFGFR1? is a driver isoform of FGFR1 alternative splicing in breast cancer cells. Oncotarget. 2019 Jan 01; 10(1):30-44.Oncotarget2019-01-01T00:00:002019FGFR1? is a driver isoform of FGFR1 alternative splicing in breast cancer cells.D00007400833520.963088MDS1 and EVI1 Complex Locus ProteinD064726Disorders31811970.485786Triple Negative Breast Neoplasms17291453Bhattacharya C, Aggarwal S, Zhu R, Kumar M, Zhao M, Meistrich ML, Matin ABiochemical and biophysical research communicationsThe mouse dead-end gene isoform alpha is necessary for germ cell and embryonic viability. Biochem Biophys Res Commun. 2007 Mar 30; 355(1):194-9.Biochem Biophys Res Commun2007-02-02T00:00:002007The mouse dead-end gene isoform alpha is necessary for germ cell and embryonic viability.23627452Lu G, Muddasani R, Orlowski RZ, Abruzzo LV, Qazilbash MH, You MJ, Wang Y, Zhao M, Chen S, Glitza IC, Medeiros LJArchives of pathology & laboratory medicinePlasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasms. Arch Pathol Lab Med. 2013 May; 137(5):625-31.Arch Pathol Lab Med2013-05-01T00:00:002013Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasms.Authorship 9515311831285952Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang BAmerican journal of cancer researchGlutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization. Am J Cancer Res. 2019; 9(6):1201-1211.Am J Cancer Res2019-06-01T00:00:002019Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization.Authorship 962900131857856Zhao M, Zhuo ML, Zheng X, Su X, Meric-Bernstam FOncotargetCorrection: FGFR1? is a driver isoform of FGFR1 alternative splicing in breast cancer cells. Oncotarget. 2019 Dec 10; 10(65):7014-7015.Oncotarget2019-12-10T00:00:002019Correction: FGFR1? is a driver isoform of FGFR1 alternative splicing in breast cancer cells.Authorship 980107232215185Owusu-Brackett N, Zhao M, Akcakanat A, Evans KW, Yuca E, Dumbrava EI, Janku F, Meric-Bernstam FOncotargetTargeting PI3K? alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss. Oncotarget. 2020 Mar 17; 11(11):969-981.Oncotarget2020-03-17T00:00:002020Targeting PI3K? alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss.Authorship 992539532576238Guo H, Ding Q, Gong Y, Gilcrease MZ, Zhao M, Zhao J, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo LBreast cancer research : BCRComparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors. Breast Cancer Res. 2020 06 23; 22(1):69.Breast Cancer Res2020-06-23T00:00:002020Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors.Authorship 995440232712217MacKenzie KR, Zhao M, Barzi M, Wang J, Bissig KD, Maletic-Savatic M, Jung SY, Li FEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical SciencesMetabolic profiling of norepinephrine reuptake inhibitor atomoxetine. Eur J Pharm Sci. 2020 Oct 01; 153:105488.Eur J Pharm Sci2020-07-23T00:00:002020Metabolic profiling of norepinephrine reuptake inhibitor atomoxetine.Authorship 1005469633221342Huang X, Ding Q, Guo H, Gong Y, Zhao J, Zhao M, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo LHuman pathologyComparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma. Hum Pathol. 2021 02; 108:42-50.Hum Pathol2020-11-19T00:00:002020Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma.Twitter Tweets Harvard TweetsAuthorship 1008415133414137Zhao M, Scott S, Evans KW, Yuca E, Saridogan T, Zheng X, Wang H, Korkut A, Cruz Pico CX, Demirhan M, Kirby B, Kopetz S, Diala I, Lalani AS, Piha-Paul S, Meric-Bernstam FClinical cancer research : an official journal of the American Association for Cancer ResearchCombining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer. Clin Cancer Res. 2021 03 15; 27(6):1681-1694.Clin Cancer Res2021-01-07T00:00:002021Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer.Authorship 1012755233663585Pairawan S, Zhao M, Yuca E, Annis A, Evans K, Sutton D, Carvajal L, Ren JG, Santiago S, Guerlavais V, Akcakanat A, Tapia C, Yang F, Bose PSC, Zheng X, Dumbrava EI, Aivado M, Meric-Bernstam FBreast cancer research : BCRFirst in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. Breast Cancer Res. 2021 03 04; 23(1):29.Breast Cancer Res2021-03-04T00:00:002021First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models.Authorship 10190353334017325Mendt M, Daher M, Basar R, Shanley M, Kumar B, Wei Inng FL, Acharya S, Shaim H, Fowlkes N, Tran JP, Gokdemir E, Uprety N, Nunez-Cortes AK, Ensley E, Mai T, Kerbauy LN, Melo-Garcia L, Lin P, Shen Y, Mohanty V, Lu J, Li S, Nandivada V, Wang J, Banerjee P, Reyes-Silva F, Liu E, Ang S, Gilbert A, Li Y, Wan X, Gu J, Zhao M, Baran N, Muniz-Feliciano L, Wilson J, Kaur I, Gagea M, Konopleva M, Marin D, Tang G, Chen K, Champlin R, Rezvani K, Shpall EJFrontiers in immunologyMetabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD. Front Immunol. 2021; 12:631353.Front Immunol2021-05-04T00:00:002021Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD.34518211Evans KW, Yuca E, Scott SS, Zhao M, Paez Arango N, Cruz Pico CX, Saridogan T, Shariati M, Class CA, Bristow CA, Vellano CP, Zheng X, Gonzalez-Angulo AM, Su X, Tapia C, Chen K, Akcakanat A, Lim B, Tripathy D, Yap TA, Francesco MED, Draetta GF, Jones P, Heffernan TP, Marszalek JR, Meric-Bernstam FCancer researchOxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancer Res. 2021 11 01; 81(21):5572-5581.Cancer Res2021-09-13T00:00:002021Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer.Authorship 10296674Authorship 1036426134974290Zhao M, Medeiros LJ, Wang W, Tang G, Jung HS, Sfamenos SM, Fang H, Toruner GA, Hu S, Yin CC, Lin P, Gu J, Peng G, You MJ, Khoury JD, Wang SA, Tang ZCancer geneticsNewly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies. Cancer Genet. 2022 04; 262-263:23-29.Cancer Genet2021-12-23T00:00:002021Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies.Authorship 10404891235075200Pairawan S, Akcakanat A, Kopetz S, Tapia C, Zheng X, Chen H, Ha MJ, Rizvi Y, Holla V, Wang J, Evans KW, Zhao M, Busaidy N, Fang B, Roth JA, Dumbrava EI, Meric-Bernstam FScientific reportsCombined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations. Sci Rep. 2022 01 24; 12(1):1248.Sci Rep2022-01-24T00:00:002022Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations.Authorship 10438683Authorship 1044680635417734Shen T, Zhao J, Zhao M, Taggart MW, Ramalingam P, Gong Y, Wu Y, Liu H, Zhang J, Resetkova E, Wang WL, Ding Q, Huo L, Yoon EHuman pathologyUnusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfall. Hum Pathol. 2022 07; 125:35-47.Hum Pathol2022-04-10T00:00:002022Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfall.35484100Cai T, Gouble A, Black KL, Skwarska A, Naqvi AS, Taylor D, Zhao M, Yuan Q, Sugita M, Zhang Q, Galetto R, Filipe S, Cavazos A, Han L, Kuruvilla V, Ma H, Weng C, Liu CG, Liu X, Konoplev S, Gu J, Tang G, Su X, Al-Atrash G, Ciurea S, Neelapu SS, Lane AA, Kantarjian H, Guzman ML, Pemmaraju N, Smith J, Thomas-Tikhonenko A, Konopleva MNature communicationsTargeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells. Nat Commun. 2022 04 28; 13(1):2228.Nat Commun2022-04-28T00:00:002022Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.36405699Wu Q, Ning K, Zhao X, Liao F, Wang M, Chang L, Liu Y, Chen J, Zhao M, Chen ZFrontiers in immunologyEditorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases. Front Immunol. 2022; 13:1069918.Front Immunol2022-11-02T00:00:002022Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases.Authorship 106285016Authorship 1062839936073141Patel S, Ershad F, Lee J, Chacon-Alberty L, Wang Y, Morales-Garza MA, Haces-Garcia A, Jang S, Gonzalez L, Contreras L, Agarwal A, Rao Z, Liu G, Efimov IR, Zhang YS, Zhao M, Isseroff RR, Karim A, Elgalad A, Zhu W, Wu X, Yu CSmall (Weinheim an der Bergstrasse, Germany)Drawn-on-Skin Sensors from Fully Biocompatible Inks toward High-Quality Electrophysiology. Small. 2022 09; 18(36):e2107099.Small2022-02-19T00:00:002022Drawn-on-Skin Sensors from Fully Biocompatible Inks toward High-Quality Electrophysiology.Authorship 1072954437279095DiPeri TP, Evans KW, Raso MG, Zhao M, Rizvi YQ, Zheng X, Wang B, Kirby BP, Kong K, Kahle M, Yap TA, Dumbrava EE, Ajani JA, Fu S, Keyomarsi K, Meric-Bernstam FClinical cancer research : an official journal of the American Association for Cancer ResearchAdavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. Clin Cancer Res. 2023 11 01; 29(21):4385-4398.Clin Cancer Res2023-11-01T00:00:002023Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.true1ProfessorProfessorDepartment of Biochemistry and Molecular PharmacologyBiochemistry & Mol Pharmacologytrue1ProfessorProfessortrue1Assistant Professor - SHPAssistant Professor - SHPtrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professor24030742Jaso JM, Yin CC, Lu VW, Zhao M, Abruzzo LV, You MJ, Yang Y, Luthra R, Medeiros LJ, Lu GModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncB acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease. Mod Pathol. 2014 Mar; 27(3):382-9.Mod Pathol2013-09-13T00:00:002013B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease.25531746Jiang X, Yu Y, Chen J, Zhao M, Chen H, Song X, Matzuk AJ, Carroll SL, Tan X, Sizovs A, Cheng N, Wang MC, Wang JACS chemical biologyQuantitative imaging of glutathione in live cells using a reversible reaction-based ratiometric fluorescent probe. ACS Chem Biol. 2015 Mar 20; 10(3):864-74.ACS Chem Biol2015-01-06T00:00:002015Quantitative imaging of glutathione in live cells using a reversible reaction-based ratiometric fluorescent probe.